Balancing Autonomy and Anatomy: Bombay High Court Re-evaluates IVF Age Caps

MUMBAI — In a landmark case that challenges the intersection of legislative authority and reproductive biology, the Bombay High Court has granted interim relief to two women, aged 53 and 55, allowing them to undergo rigorous medical fitness evaluations for IVF. The decision, handed down in late April 2026, marks a pivotal moment in the legal challenge against India’s Assisted Reproductive Technology (Regulation) Act, 2021, which currently mandates a strict upper age limit of 50 for women seeking fertility treatments.

The ruling does not yet strike down the law, but it opens a clinical window for individualized assessment—a move that could reshape how “advanced maternal age” is regulated in one of the world’s most populous nations.

The Legal Threshold: Age vs. Ability

The Assisted Reproductive Technology (ART) Act of 2021 was designed to bring order to India’s burgeoning fertility industry. However, Section 21(g) of the Act established a controversial age “bracket”: 21 to 50 years for women and up to 55 years for men.

The two petitioners, both married and seeking to conceive through donor gametes (eggs), argue that this rigid cutoff is “arbitrary and discriminatory.” Their legal counsel contends that the law violates fundamental rights to equality and bodily autonomy, suggesting that if a woman is medically fit to carry a child, a calendar date should not be the sole arbiter of her reproductive future.

A division bench comprising Justices Ravindra Ghuge and Abhay Mantri opted for a cautious, evidence-based approach. Rather than issuing a blanket stay on the law, the court ordered a “battery of medical tests” to determine the petitioners’ physical capacity for pregnancy.

“The court is not saying that every woman above 50 can walk into an IVF center and be treated,” explains a Mumbai-based fertility specialist. “It is saying: first, let us see if the body is capable of the task before we debate the philosophy of the law.”

The Clinical Reality: Risks of Pregnancy After 50

While the legal debate focuses on rights, the medical debate focuses on physiology. Clinicians categorize women over 50 as being of “Very Advanced Maternal Age” (VAMA). According to data from the National Institutes of Health (NIH) and various epidemiological studies, pregnancy in this demographic is viewed as a significant cardiovascular “stress test.”

Documented Risks for Women Over 50:

• Hypertensive Disorders: A significantly higher incidence of preeclampsia and chronic hypertension.

• Gestational Diabetes: Increased metabolic strain often leads to blood sugar regulation issues.

• Placental Complications: Higher risks of placenta previa or abruption.

• Obstetric Intervention: A near-universal rate of Cesarean sections in this age group.

Furthermore, ART itself introduces complexities. The transfer of multiple embryos can lead to twin or triplet pregnancies, which exponentially increase the risk of preterm birth and low birth weight—complications that are harder for an older mother’s body to manage.

Expert Commentary: A “Reasonable Compromise”

Medical experts are divided but largely supportive of the court’s nuanced interim step. Dr. Amrita Singh, a reproductive endocrinologist (independent of the case), notes that “biological age and chronological age don’t always move in lockstep.”

“What matters most are comorbidities,” says Dr. Singh. “A healthy 52-year-old with no history of hypertension or diabetes might actually have a lower risk profile than a 38-year-old with chronic kidney disease. By ordering fitness tests, the court is moving toward a precision medicine model rather than a ‘one-size-fits-all’ legislative model.”

However, others caution against optimism. Ethical concerns linger regarding the long-term welfare of the child. Critics argue that “older motherhood” raises the statistical probability of a child losing a parent during their formative years. There is also the “resource allocation” argument: should a strained healthcare system prioritize high-risk, high-cost VAMA pregnancies over younger populations with a higher success rate?

Global Context and Future Implications

India is not alone in this struggle. The European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) generally discourage ART for women over 50 but allow for “carefully selected” cases following multi-disciplinary screening.

If the Bombay High Court eventually rules that the age cap is unconstitutional, it could lead to:

1. Mandatory Pre-IVF Screening: Standardized protocols including echocardiography, renal function tests, and psychological counseling for women over 45.

2. Robust Informed Consent: Legal requirements for clinics to provide absolute risk numbers, ensuring patients understand the low success rates and high complication risks.

3. Single Embryo Transfer (SET) Mandates: To minimize the danger of multiple births in older patients.

What This Means for You

For the health-conscious consumer, this case serves as a reminder that while technology can extend the reproductive window, it cannot entirely bypass biology.

• For Women in their 40s/50s: If you are considering ART, the evolving legal landscape may offer more flexibility, but it comes with the responsibility of rigorous health maintenance. Individualized fitness—not just legal permission—is the true gatekeeper.

• For Healthcare Providers: The ruling underscores the necessity of documentation. Clear communication regarding the distinction between “technically possible” and “clinically advisable” is paramount.

The court has appointed an amicus curiae (friend of the court) to gather further scientific data. As the case proceeds, the medical community and hopeful parents alike await a verdict that will define the boundaries of science, law, and the human desire for family.

Reference Section

Legal and News Sources:

• NDTV: “2 Women Challenge IVF Age Cap, Bombay High Court Allows Fitness Tests For Now.” (April 22, 2026).

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.